The dynamic blood-brain barrier

FEBS Journal

Volumn 282, Issue 21, 2015, Pages 4067-4079

  Keaney, James ^a   Campbell, Matthew ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Alzheimer's disease; astrocytes; blood brain barrier; GLUT 1; gut microbiota; Mfsd2a; neurovascular unit; pericytes; tight junctions; transcytosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; CADHERIN; GLUCOSE TRANSPORTER 1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NEUROTRANSMITTER; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN ZO1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VASCULAR ENDOTHELIAL CADHERIN; MFSD2A PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BACTERIAL MENINGITIS; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN ISCHEMIA; CELL CONTACT; CELL JUNCTION; CELLS BY BODY ANATOMY; CENTRAL NERVOUS SYSTEM DISEASE; CHROMATIN ASSEMBLY AND DISASSEMBLY; COGNITION; CROSS LINKING; DYNAMICS; ENDOTHELIUM CELL; GENE; GENETIC ANALYSIS; GLUCOSE METABOLISM; HOMEOSTASIS AND REGULATION; HUMAN; IMMUNITY; INFECTION; INNATE IMMUNITY; INTEGRATION; INTESTINE FLORA; LYMPHOCYTE MIGRATION; MEDICAL RESEARCH; MFSD2A GENE; MICROCEPHALY; MICROENVIRONMENT; MICROGLIA; MISSENSE MUTATION; NEURAL MICROENVIRONMENT; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PDGFR BETA GENE; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SLC2A1 GENE; SLEEP WAKING CYCLE; SYNAPSE; T LYMPHOCYTE; TIGHT JUNCTION; TRANSCYTOSIS; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; CEREBROVASCULAR ACCIDENT; CYTOLOGY; GENETICS; IMMUNOLOGY; PHYSIOLOGY; SLEEP; VASCULAR ENDOTHELIUM; VASCULARIZATION;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; BASEMENT MEMBRANE; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; ENDOTHELIUM, VASCULAR; GASTROINTESTINAL MICROBIOME; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNITY, INNATE; MICROGLIA; PERICYTES; SLEEP; STROKE; TIGHT JUNCTIONS; TRANSCYTOSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84945457224     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13412     Document Type: Article

References (111)

1. Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, &, Begley DJ, (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37, 13-25.
2. Saunders NR, Liddlelow SA, &, Dziegielewska KM, (2012) Barrier mechanisms in the developing brain. Front Pharmacol 3, 1-18.
3. Engelhardt B, &, Liebner S, (2014) Novel insights into the development and maintenance of the blood-brain barrier. Cell Tissue Res 355, 687-699.
4. Obermeier B, Daneman R, &, Ransohoff R, (2013) Development, maintenance and disruption of the blood-brain barrier. Nat Med 19, 1584-1596.
5. Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, et al,. (2015) GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18, 521-530.
6. Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, Wenk MR, Goh EL, &, Silver DL, (2014) Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 509, 503-506.
7. Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, &, Gu C, (2014) Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature 509, 507-511.
8. Luissint AC, Artus C, Glacial F, Ganeshamoorthy K, &, Couraud PO, (2012) Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 9, 9-23.
9. Lampron A, Elali A, &, Rivest S, (2013) Innate immunity in the CNS: redefining the relationship between the CNS and its environment. Neuron 78, 214-232.
10. Stewart PA, &, Wiley MJ, (1981) Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev Biol 84, 183-192.
11. Rodríguez-Arellano JJ, Parpura V, Zorec R, &, Verkhratsky A, (2015) Astrocytes in physiological aging and Alzheimer's disease. Neuroscience. doi: 10.1016/j.neuroscience.2015.01.007 (in press).
12. Abbott NJ, Rönnbäck L, &, Hansson E, (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7, 41-53.
13. Zlokovic BV, (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-195.
14. Tait MJ, Saadoun S, Bell BA, &, Papadopoulos MC, (2008) Water movements in the brain: role of aquaporins. Trends Neurosci 31, 37-43.
15. Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonnière L, Bernard M, et al,. (2011) The hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 334, 1727-1731.
16. Wosik K, Cayrol R, Dodelet-Devillers A, Berthelet F, Bernard M, Moumdjian R, Bouthillier A, Reudelhuber TL, &, Prat A, (2007) Angiotensin II controls occludin function and is required for blood-brain barrier maintenance: relevance to multiple sclerosis. J Neurosci 27, 9032-9042.
17. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, et al,. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512-516.
18. Nishitsuji K, Hosono T, Nakamura T, Bu G, &, Michikawa M, (2011) Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem 286, 17536-17542.
19. Janzer RC, &, Raff MC, (1987) Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325, 253-257.
20. Holash JA, Noden DM, &, Stewart PA, (1993) Re-evaluating the role of astrocytes in blood-brain barrier induction. Dev Dyn 197, 14-25.
21. Dehouck MP, Meresse S, Delorme P, Fruchart JC, &, Cecchelli R, (1990) An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem 54, 1798-1801.
22. Hayashi Y, Nomura M, Yamagishi S, Harada S, Yamashita J, &, Yamamoto H, (1997) Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia 19, 13-26.
23. Daneman R, Zhou L, Kebede AA, &, Barres BA, (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566.
24. Mizee MR, Wooldrik D, Lakeman KA, van het Hof B, Drexhage JA, Geerts D, Bugiani M, Aronica E, Mebius RE, Prat A, et al,. (2013) Retinoic acid induces blood-brain barrier development. J Neurosci 33, 1660-1671.
25. Winkler EA, Bell RD, &, Zlokovic BV, (2011) Central nervous system pericytes in health and disease. Nat Neurosci 14, 1398-1405.
26. Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O'Farrell FM, Buchan AM, Lauritzen M, &, Atwell D, (2014) Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508, 55-60.
27. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupolla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, et al,. (2008) Wnt/β-catenin signaling controls development of the blood-brain barrier. J Cell Biol 183, 409-417.
28. Stenman J, Rajagopal J, Carroll TJ, Ishibashi M, McMahon J, &, McMahon AP, (2008) Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322, 1247-1250.
29. Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, &, Barres BA, (2009) Wnt/β-catenin is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci USA 106, 641-646.
30. Tam SJ, Richmond DL, Kaminker JS, Modrusen Z, Martin-McNulty B, Cao TC, Weimer RW, Carano RAD, van Bruggen N, &, Watts R, (2012) Death receptors DR6 and TROY regulate brain vascular development. Dev Cell 22, 403-417.
31. Cullen M, Elzarrad MK, Seaman S, Zudaire E, Stevens J, Yang MY, Li X, Chaudhary A, Xu L, Hilton MB, et al,. (2011) GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier. Proc Natl Acad Sci USA 108, 5759-5764.
32. Zhou Y, &, Nathans J, (2014) Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling. Dev Cell 31, 248-256.
33. Lindahl P, Johansson BR, Leveen P, &, Betsholtz C, (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245.
34. Li F, Lan Y, Wang Y, Wang J, Yang G, Meng F, Han H, Meng A, Wang Y, &, Yang X, (2011) Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev Cell 20, 291-302.
35. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, &, Zlokovic B, (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427.
36. Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, et al,. (2010) Pericytes regulate the blood-brain barrier. Nature 468, 557-561.
37. Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, &, Zlokovic BV, (2013) Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun 4, 2932.
38. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, &, Gokhan S, (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845.
39. Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S, Peri F, Wilson SW, &, Ruhrberg C, (2010) Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116, 829-840.
40. da Fonseca AC, Matias D, Garcia C, Amaral R, Geraldo LH, Freitas C, &, Lima FR, (2014) The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci 8, 362.
41. Aguzzi A, Barres BA, &, Bennett ML, (2013) Microglia: scapegoat, saboteur, or something else? Science 339, 156-161.
42. Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, Mahad D, Bradl M, van Horssen J, &, Lassmann H, (2012) NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135, 886-899.
43. Rochfort KD, Collins LE, Murphy RP, &, Cummins PM, (2014) Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS ONE 9, e101815.
44. Yang YM, Shang DS, Zhao WD, Fang WG, &, Chen YH, (2013) Microglial TNF-α-dependent elevation of MHC class I expression on brain endothelium induced by amyloid-beta promotes T cell transendothelial migration. Neurochem Res 38, 2295-2304.
45. Yin X, Wright J, Wall T, &, Grammas P, (2010) Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease. Am J Pathol 176, 1600-1606.
46. Huang CF, Li G, Ma R, Sun SG, &, Chen JG, (2008) Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo. Neurosci Bull 24, 66-72.
47. Hickey WF, &, Kimura H, (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290-292.
48. Yao Y, Chen ZL, Norris EH, &, Strickland S, (2014) Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun 5, 3413.
49. Pardridge WM, (2009) Alzheimer's disease drug development and the problem of the blood-brain barrier. Alzheimer's Dement 5, 427-432.
50. Harik SI, Kalaria RN, Andersson L, Lundahl P, &, Perry G, (1990) Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions. J Neurosci 10, 3862-3872.
51. Rotstein M, Engelstad K, Yang H, Wang D, Levy B, Chung WK, &, De Vivo DC, (2010) Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann Neurol 68, 955-958.
52. Mooradian AD, Chung HC, &, Shah GN, (1997) GLUT1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol Aging 18, 469-474.
53. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ, & Alzheimer's Disease Neuroimaging Initiative (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32, 1207-1218.
54. Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, &, Schröder J, (2007) Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Psychiatry Res 155, 147-154.
55. Herholz K, (2010) Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease. Expert Rev Neurother 10, 1667-1673.
56. Alakbarzade V, Hameed A, Quek DQ, Chioza BA, Baple EL, Cazenave-Gassiot A, Nguyen LN, Wenk MR, Ahmad AQ, Sreekantan-Nair A, et al,. (2015) A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome. Nat Genet. doi: 10.1038/ng.3313.
57. Guemez-Gamboa A, Nguyen LN, Yang H, Zaki MS, Kara M, Ben-Omran T, Akizu N, Rosti RO, Rosti B, Scott E, et al,. (2015) Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome. Nat Genet. doi: 10.1038/ng.3311.
58. Roberts KF, Elbert DL, Kasten TP, Patterson BW, Sigurdson WC, Connors RE, Ovod V, Munsell LY, Mawuenyega KG, Miller-Thomas MM, et al,. (2014) Amyloid-β efflux from the central nervous system into the plasma. Ann Neurol 76, 837-844.
59. Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, et al,. (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115, 3285-3290.
60. Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I, Cascorbi I, Walker LC, Kroemer HK, Warzok RW, et al,. (2007) MDR1-P-Glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides-implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol 17, 347-353.
61. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, et al,. (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9, 907-913.
62. Kanekiyo T, Cirrito JR, Liu CC, Shinohara M, Li J, Schuler DR, Shinohara M, Holtzman DM, &, Bu G, (2013) Neuronal clearance of amyloid-beta by endocytic receptor LRP1. J Neurosci 33, 19276-19283.
63. Kanekiyo T, Liu CC, Shinohara M, Li J, &, Bu G, (2012) LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-beta. J Neurosci 32, 16458-16465.
64. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, et al,. (2004) LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43, 333-344.
65. Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I, Streb JW, Guo H, Rubio A, Van Nostrand W, et al,. (2009) SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 11, 143-153.
66. Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K, Winkler EA, Ramanathan A, Kanekiyo T, Bu G, et al,. (2015) Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance. Nat Neurosci 18, 978-987.
67. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, et al,. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41, 1088-1093.
68. Bazzoni G, &, Dejana E, (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84, 869-901.
69. Hawkins BT, &, Davis TP, (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57, 173-185.
70. Tietz S, &, Engelhardt B, (2015) Brain barriers: crosstalk between complex tight junctions and adherens junctions. J Cell Biol 4, 493-506.
71. Haseloff RF, Dithmer S, Winkler L, Wolburg H, &, Blasig IE, (2015) Transmembrane proteins of the tight junctions at the blood-brain barrier: Structural and functional aspects. Semin Cell Dev Biol 38, 16-25.
72. Daneman R, Zhou L, Agalliu D, Cahoy JD, Kaushal A, &, Barres BA, (2010) The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE 5, 1-16.
73. Fanning AS, Jameson BJ, Jesaitis LA, &, Anderson JM, (1998) The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273, 29745-29753.
74. Iwamoto N, Higashi T, &, Furuse M, (2014) Localization of angulin-1/LSR and tricellulin at tricellular contacts of brain and retinal endothelial cells in vivo. Cell Struct Funct 39, 1-8.
75. Sohet F, Lin C, Munji RN, Lee SY, Ruderisch N, Soung A, Arnold TD, Derugin N, Vexler ZS, Yen FT, et al,. (2015) LSR/angulin-1 is a tricellular tight junction protein involved in blood-brain barrier formation. J Cell Biol 208, 703-711.
76. Tornavaca O, Chia M, Dufton N, Almagro LO, Conway DE, Randi AM, Schwartz MA, Matter K, &, Balda MS, (2015) ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol 208, 821-838.
77. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, &, Dejana E, (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10, 923-934.
78. Walsh TG, Murphy RP, Fitzpatrick P, Rochfort KD, Guinan AF, Murphy A, &, Cummins PM, (2011) Stabilization of brain microvascular endothelial barrier function by shear stress involves VE-cadherin signaling leading to modulation of pTyr-occludin levels. J Cell Physiol 226, 3053-3063.
79. Alvarez JI, Saint-Laurent O, Godschalk A, Terouz S, Briels C, Larouche S, Bourbonnière L, Larochelle C, &, Prat A, (2015) Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions. Neurobiol Dis 74, 14-24.
80. Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, Stojanovic K, Sagare A, Boillee S, Cleveland DW, et al,. (2008) ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11, 420-422.
81. Miyazaki K, Ohta Y, Nagai M, Morimoto N, Kurata T, Takehisa Y, Ikeda Y, Matsuura T, &, Abe K, (2011) Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J Neurosci Res 89, 718-728.
82. Hartz AMS, Bauer B, Soldner LB, Wolf A, Boy S, Backhaus R, Mihaljevic I, Bogdahn U, Klunemann HH, Schuierer G, et al,. (2011) Amyloid-beta contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 43, 514-523.
83. Khatri R, McKinney AM, Swenson B, &, Janardhan V, (2012) Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology 79, S52-S57.
84. Sandoval KE, &, Witt KA, (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32, 200-219.
85. Knowland D, Arac A, Sekiguchi KJ, Hsu M, Lutz SE, Perrino J, Steinberg GK, Barres BA, Nimmerjahn A, &, Agalliu D, (2014) Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron 82, 603-617.
86. Nag S, Venugopalan R, &, Stewart DJ, (2007) Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol 114, 459-469.
87. Campbell M, Hanrahan F, Gobbo OL, Kelly ME, Kiang AS, Humphries MM, Nguyen ATH, Ozaki E, Keaney J, Blau CW, et al,. (2012) Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury. Nat Commun 3, Article 849.
88. Greenwood J, Wang Y, &, Calder VL, (1995) Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. Immunology 86, 408-415.
89. Sagar D, Lamontagne A, Foss CA, Khan ZK, Pomper MG, &, Jain P, (2012) Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation. J Neuroinflammation 9, 245.
90. Winger RC, Koblinski JE, Kanda T, Ransohoff RM, &, Muller WA, (2014) Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood-brain barrier. J Immunol 193, 2427-2437.
91. Larochelle C, Alvarez JI, &, Prat A, (2011) How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett 585, 3770-3780.
92. Simard AR, Soulet D, Gowing G, Julien JP, &, Rivest S, (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489-502.
93. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, Cohen H, Kipnis J, &, Schwartz M, (2006) Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9, 268-275.
94. Sáez-Llorens X, &, McCracken GH Jr, (2003) Bacterial meningitis in children. Lancet 361, 2139-2148.
95. Kim BJ, Hancock BM, Bermudez A, Cid ND, Reyes E, van Sorge NM, Lauth X, Smurthwaite CA, Hilton BJ, Stotland A, et al,. (2015) Bacterial induction of Snail1 contributes to blood-brain barrier disruption. J Clin Invest 125, 2473-2483.
96. Roe K, Kumar M, Lum S, Orillo B, Nerurkar VR, &, Verma S, (2012) West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virol 93, 1193-1203.
97. Lazear HM, Daniels BP, Pinto AK, Huang AC, Vick SC, Doyle SE, Gale M Jr, Klein RS, &, Diamond MS, (2015) Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med 7, 284ra59.
98. Siegel JM, (2005) Clues to the functions of mammalian sleep. Nature 437, 1264-1271.
99. Kawakami N, Takatsuka N, &, Shimizu H, (2004) Sleep disturbance and onset of type 2 diabetes. Diabetes Care 27, 282-283.
100. Gõmez-González B, Hurtado-Alvarado G, Esqueda-Leõn E, Santana-Miranda R, Rojas-Zamorano JÁ, &, Velázquez-Moctezuma J, (2013) REM sleep loss and recovery regulates blood-brain barrier function. Curr Neurovasc Res 10, 197-207.
101. He J, Hsuchou H, He Y, Kastin AJ, Wang Y, &, Pan W, (2015) Sleep restriction impairs blood-brain barrier function. J Neurosci 34, 14697-14706.
102. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O'Donnell J, Christensen DJ, Nicholson C, Iliff JJ, et al,. (2013) Sleep drives metabolic clearance from the adult brain. Science 342, 373-377.
103. Cryan JF, &, Dinan TG, (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13, 701-712.
104. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tõth M, Korecka A, Bakocevic N, Ng LG, Kundu P, et al,. (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6, 263ra158.
105. Zlokovic BV, (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12, 723-738.
106. Erickson MA, &, Banks WA, (2013) Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab 33, 1500-1513.
107. Bake S, Friedman JA, &, Sohrabji F, (2009) Reproductive age-related changes in the blood brain barrier: expression of IgG and tight junction proteins. Microvasc Res 78, 413-424.
108. De Reuck JL, (2012) Histopathological stainings and definitions of vascular disruptions in the elderly brain. Exp Gerontol 47, 834-837.
109. Farrall AJ, &, Wardlaw JM, (2009) Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol Aging 30, 337-352.
110. Chen RL, (2011) Is it appropriate to use albumin CSF/plasma ratio to assess blood brain barrier permeability? Neurobiol Aging 32, 1338-1339.
111. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, et al,. (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85, 296-302.